Teradyne, Inc. director Marilyn Matz filed a Form 144 notice on November 18, 2026, disclosing a proposed sale of 800 shares of Teradyne common stock through Fidelity Brokerage Services LLC on NASDAQ:TER.

Key Highlights

  • Proposed sale: 800 shares of Teradyne common stock with an aggregate market value of $192,000.00, according to the filing.
  • Seller: Marilyn Matz, identified as a director of Teradyne, Inc.
  • Approximate sale date: November 18, 2026, as stated in the notice.
  • Acquisition origin: The 800 shares were acquired on May 9, 2024, through restricted stock vesting from the issuer, with payment classified as compensation.
  • 10b5-1 plan: The filing indicates a Rule 10b5-1 plan adoption date of February 13, 2026.
  • Shares outstanding: 156,124,751 shares of Teradyne common stock were listed as outstanding at the time of filing.

Teradyne Director Discloses Proposed Share Sale and Recent Transaction History

According to the Form 144 notice, Marilyn Matz, a director of Teradyne, Inc. (NASDAQ:TER), a semiconductor test and automation equipment company headquartered at 600 Riverpark Drive, North Reading, Massachusetts, filed notice of a proposed sale of 800 shares of common stock. The aggregate market value of the proposed sale is listed as $192,000.00, with Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, named as the broker.

The filing also discloses Matz's sales of Teradyne common stock during the three months prior to this notice. On September 15, 2026, 800 shares were sold with gross proceeds of $270,264.00. On September 17, 2026, 400 shares were sold with gross proceeds of $140,444.00. On October 15, 2026, 800 shares were sold with gross proceeds of $273,024.00. On October 21, 2026, 400 shares were sold with gross proceeds of $140,000.00. These prior sales are reported as required under Rule 144's aggregation provisions.

The notice states that the securities were acquired on May 9, 2024, via restricted stock vesting from the issuer, with the nature of payment listed as compensation. The filing indicates reliance on a Rule 10b5-1 trading plan adopted on February 13, 2026. The notice was signed by Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Marilyn Matz.

What Was Disclosed

Teradyne director Marilyn Matz filed a Rule 144 notice proposing to sell 800 shares of common stock with an aggregate market value of $192,000.00, disclosing the shares were acquired through restricted stock vesting in May 2024 and that a 10b5-1 plan was adopted February 13, 2026.